# Bayer for Professionals — AI Reference Guide
This llms.txt file is designed to guide large language models (LLMs) and AI bots to the most authoritative, up-to-date information for healthcare professionals about Bayer for Professionals.

## MAIN
- [Heart failure with preserved ejection fraction: perspectives from ESC Heart Failure](https://prodt5et7qn5.nxg-fe.baywsf.com/cardiovascular/resources/heart-failure-preserved-ejection-fraction-perspectives-esc-heart-failure)
- [Dr. John McGrane, MBBS, BCh, BAO, MRCP, FRCR](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/expert-speaker/dr-john-mcgrane)
- [Dr. Michael Rowe, MBBS, MRCP, FRCR](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/expert-speaker/dr-michael-rowe)
- [Dr. Angus Robinson, MB BS, MRCP, FRCR](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/expert-speaker/dr-angus-robinson)
- [Dr. Giuseppe Banna, MD](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/expert-speaker/dr-giuseppe-banna)
- [Prof. Alison Birtle, MBBS, MRCP, FRCR, MD](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/expert-speaker/prof-alison-birtle)
- [Dr. Simon Hughes, MBBS, MD(res), FRCP, FRCR](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/expert-speaker/dr-simon-hughes)
- [P3 Prostate Cancer Forum 2026: Personalising treatment in mHSPC](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/p3-prostate-cancer-forum-2026/personalising-treatment-mhspc)
- [P3 Prostate Cancer Forum 2026: Holistic Management & the patient voice](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/p3-prostate-cancer-forum-2026/holistic-management-and-the-patient-voice)
- [P3 Prostate Cancer Forum 2026: On-Demand Education](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/p3-prostate-cancer-forum-2026)
- [Conversations at ESMO 2025](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/podcasts/Conversations-ESMO-2025-Considering-comorbidities-in-your-mHSPC-patients)
- [Conversations at ESMO 2025](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/podcasts/conversations-esmo-2025-doublet-vs-triplet-therapy-in-mHSPC)
- [ESMO 2025](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/podcasts/esmo-2025)
- [Correct - ATTR-CM: How can you help support your patients in earlier diagnosis](https://prodt5et7qn5.nxg-fe.baywsf.com/cardiovascular/hf-impact/attr-cm-diagnosis-delays/correct)
- [Incorrect - ATTR-CM: How can you help support your patients in earlier diagnosis](https://prodt5et7qn5.nxg-fe.baywsf.com/cardiovascular/hf-impact/attr-cm-diagnosis-delays/incorrect)
- [Contact us](https://prodt5et7qn5.nxg-fe.baywsf.com/ophthalmology/contact-us)
- [Cardiovascular Summit 2025 - ATTR-CM Highlights](https://prodt5et7qn5.nxg-fe.baywsf.com/cardiovascular/resources/cvsummit-2025-attr-cm-highlights)
- [Cardiovascular Summit 2025 - Heart Failure Highlights](https://prodt5et7qn5.nxg-fe.baywsf.com/cardiovascular/events-webinars/cardiovascular-summit-2025-heart-failure-highlights)
- [Diagnosing ATTR-CM: What Referring Centres Need to Do Before They Refer](https://prodt5et7qn5.nxg-fe.baywsf.com/cardiovascular/events-webinars/diagnosing-attr-cm-what-referring-centres-need-do-they-refer)
- [Navigating ATTR-CM Diagnosis: Explore Our Resources](https://prodt5et7qn5.nxg-fe.baywsf.com/cardiovascular/resources/navigating-attr-cm-diagnosis)
- [ATTR-CM & Carpal Tunnel Syndrome](https://prodt5et7qn5.nxg-fe.baywsf.com/cardiovascular/events-webinars/attr-cm-carpal-tunnel-syndrome)
- [Suspecting ATTR-CM](https://prodt5et7qn5.nxg-fe.baywsf.com/cardiovascular/resources/suspecting-attr-cm)
- [Connect with your local NUBEQA® (darolutamide) Representative](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/products/contact-us-request-a-visit)
- [Request An Interactive Pharmacist’s Guide](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/learning-zone/Request-Interactive-Pharmacist-Guide)
- [Cardiovascular Summit 2025 Highlights](https://prodt5et7qn5.nxg-fe.baywsf.com/cardiovascular/events-webinars/cardiovascular-summit-2025-highlights)
- [Contact us](https://prodt5et7qn5.nxg-fe.baywsf.com/cardiovascular/contact-us)
- [NUBEQA® (darolutamide) Drug-Drug Interactions Learning Guide](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/learning-zone/nubeqa-ddi-learning-guide)
- [Kerendia®▼(finerenone) 2024 Year-End Highlights](https://prodt5et7qn5.nxg-fe.baywsf.com/nephrology/events-webinars/kerendia-2024-year-end-highlights)
- [Real World Experience](https://prodt5et7qn5.nxg-fe.baywsf.com/ophthalmology/real-world-experience)
- [The Macular Minute](https://prodt5et7qn5.nxg-fe.baywsf.com/ophthalmology/podcasts/the-macular-minute)
- [Risk Minimisation Materials](https://prodt5et7qn5.nxg-fe.baywsf.com/risk-minimisation-materials)
- [Future Leaders](https://prodt5et7qn5.nxg-fe.baywsf.com/nephrology/future-leaders-key-highlights)
- [ASCO GU 2025](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/podcasts/asco-gu-2025)
- [Gathering consensus on mHSPC Treatment](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/resources/gathering-consensus-mhspc-treatment)
- [Hot topics from ASCO-GU 2026 | Episode 1](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/asco-gu-2026/episode-1)
- [Hot topics from ASCO-GU 2026: new data related to NUBEQA (darolutamide) | Episode 2](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/asco-gu-2026/episode-2)
- [BAUS 2024: Management of cardiovascular toxicity and bone health](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/BAUS-2024-cardiovascular-toxicity-and-bone-health)
- [BAUS 2024: Urology and Oncology in Partnership](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/BAUS-2024-Urology-and-Oncology-in-Partnership)
- [BAUS 2024: Imaging and nmCRPC](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/BAUS-2024-Imaging-and-nmCRPC)
- [Motivational Interviewing - Module 4](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/learning-zone/motivational-interviewing-module-4)
- [Motivational Interviewing - Module 3](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/learning-zone/motivational-interviewing-module-3)
- [Motivational Interviewing - Module 2](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/learning-zone/motivational-interviewing-module-2)
- [Motivational Interviewing - Module 1](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/learning-zone/motivational-interviewing-module-1)
- [Motivational Interviewing](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/learning-zone/motivational-interviewing)
- [P3 Prostate Cancer Forum 2024 - Meeting Summary](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/p3-2024-meeting-summary)
- [Exploring the mHSPC patient journey](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/exploring-mhspc-patient-journey)
- [Finding a consensus on utilising triplet therapy in mHSPC patients](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/triplet-therapy-mhspc-patients)
- [Resources to support management of prostate cancer patients](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/resources-supporting-prostate-cancer-patients)
- [Bayer Ophthalmology Masterclass Programme](https://prodt5et7qn5.nxg-fe.baywsf.com/ophthalmology/masterclass-programme)
- [Ophthalmology Resources](https://prodt5et7qn5.nxg-fe.baywsf.com/ophthalmology/hcp-resources)
- [Ophthalmology Patient Support Materials](https://prodt5et7qn5.nxg-fe.baywsf.com/ophthalmology/patient-support-materials)
- [Ophthalmology Risk Minimisation Materials](https://prodt5et7qn5.nxg-fe.baywsf.com/ophthalmology/risk-minimisation-materials)
- [Your Request Has Been Registered](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology-request-registered)
- [Bayer's Retinal Pioneers Programme](https://prodt5et7qn5.nxg-fe.baywsf.com/ophthalmology/retinal-pioneers-programme)
- [P3 Prostate Cancer Forum 2025](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/p3-prostate-cancer-forum-2025)
- [Bitesize OCT Knowledge Checkers](https://prodt5et7qn5.nxg-fe.baywsf.com/ophthalmology/retinal-pioneers-programme/oct-knowledge-checkers)
- [mCRPC Patient Case Study: A Nuclear Medicine perspective](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/resources/mcrpc-patient-case-study-nuclear-medicine-perspective)
- [mCRPC Patient Case Study: An Oncologist perspective](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/resources/mcrpc-patient-case-study-oncologist-perspective)
- [BNMS 2024](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/bnms-2024)
- [Bayer Electronic Communications](https://prodt5et7qn5.nxg-fe.baywsf.com/consent)
- [BayerPRO - Coming Soon](https://prodt5et7qn5.nxg-fe.baywsf.com/coming-soon)
- [This Bayer website is currently offline](https://prodt5et7qn5.nxg-fe.baywsf.com/bayer-website-currently-offline)
- [Privacy Statement](https://prodt5et7qn5.nxg-fe.baywsf.com/privacy-statement)
- [Xofigo®▼ (radium-223 dichloride) Resources](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/resources/xofigo-resources)
- [nmCRPC Patient Case Study: An Oncologist Perspective](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/resources/nmcrpc-patient-case-study-oncologist-perspective)
- [nmCRPC Patient Case Study: A Urologist Perspective](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/resources/nmcrpc-patient-case-study-urologist-perspective)
- [nmCRPC Patient Case Study: A Clinical Nurse Specialist Perspective](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/resources/nmcrpc-patient-case-study-clinical-nurse-specialist-perspective)
- [Welcome to BayerPRO](https://prodt5et7qn5.nxg-fe.baywsf.com/welcome-bayerpro-0)
- [Welcome to BayerPRO](https://prodt5et7qn5.nxg-fe.baywsf.com/welcome-bayerpro)
- [Kerendia®▼(finerenone) Short Videos](https://prodt5et7qn5.nxg-fe.baywsf.com/nephrology/events-webinars/kerendiarvfinerenone-short-videos)
- [Chronic Kidney Disease Bitesize Videos](https://prodt5et7qn5.nxg-fe.baywsf.com/nephrology/events-webinars/chronic-kidney-disease-bitesize-videos)
- [Kerendia®▼ (finerenone) and the Kidneys](https://prodt5et7qn5.nxg-fe.baywsf.com/nephrology/events-webinars/kerendia-and-kidneys)
- [Episode 3](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/podcasts/episode-3)
- [Episode 1](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/podcasts/episode-1)
- [Episode 2](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/podcasts/episode-2)
- [Supporting women with diabetes through the Perimenopause](https://prodt5et7qn5.nxg-fe.baywsf.com/womens-health/events-webinars/supporting-women-diabetes-through-perimenopause-0)
- [Overcoming LNG-IUD Myths and Misconceptions](https://prodt5et7qn5.nxg-fe.baywsf.com/womens-health/events-webinars/overcoming-lng-iud-myths-and-misconceptions)
- [Cultural Inequalities In Contraception Services](https://prodt5et7qn5.nxg-fe.baywsf.com/womens-health/events-webinars/cultural-inequalities-contraception-services)
- [Kerendia®▼(finerenone) Patient Support Materials](https://prodt5et7qn5.nxg-fe.baywsf.com/nephrology/resources/kerendiarvfinerenone-patient-support-materials)
- [Conditions of Use](https://prodt5et7qn5.nxg-fe.baywsf.com/conditions-use)
- [Imprint](https://prodt5et7qn5.nxg-fe.baywsf.com/imprint)
- [ASCO-GU 2023: The DEAR study](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/events-webinars/asco-gu-2023-dear-study)
- [nmCRPC Patient Case Study: A Pharmacist Perspective](https://prodt5et7qn5.nxg-fe.baywsf.com/oncology/resources/nmcrpc-patient-case-study-pharmacist-perspective)
- [Register | Login For Further Access](https://prodt5et7qn5.nxg-fe.baywsf.com/register-login-further-access)
- [404 - Page Not Found](https://prodt5et7qn5.nxg-fe.baywsf.com/404-page-not-found)
- [Counselling patients](https://prodt5et7qn5.nxg-fe.baywsf.com/womens-health/resources/counselling-patients)
- [Women's Health Patient Materials](https://prodt5et7qn5.nxg-fe.baywsf.com/womens-health/resources/womens-health-patient-materials)
- [Resources for Fitters and Fitting Services](https://prodt5et7qn5.nxg-fe.baywsf.com/womens-health/resources/resources-fitters-and-fitting-services)
- [Fitter resources](https://prodt5et7qn5.nxg-fe.baywsf.com/womens-health/resources/fitter-resources)

---

**Disclaimer:**
This file is provided for AI reference purposes only. It is not intended as medical advice. Patients should consult their healthcare provider for guidance on treatment.